Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Topical antipsoriatics.

K C Smith1, M Lebwohl

  • 1Mt. Sinai Medical Center, New York, New York, USA.

Skin Therapy Letter
|April 7, 2000
PubMed
Summary
This summary is machine-generated.

Topical corticosteroids are key for psoriasis treatment. Other effective topical options like tar and calcipotriol offer alternatives, especially as patients prefer non-systemic therapies for psoriasis management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Disease Burden of Generalized Pustular Psoriasis: Real-World Evidence From CorEvitas' Psoriasis Registry.

Journal of psoriasis and psoriatic arthritis·2024
Same author

Efficacy and safety of tirbanibulin 1% ointment in actinic keratoses: Data from two phase-III trials and the real-life clinical practice presented at the European Academy of Dermatology and Venereology Congress 2022.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Mild-moderate equine asthma: A scoping review of evidence supporting the consensus definition.

Veterinary journal (London, England : 1997)·2022
Same author

Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis.

The British journal of dermatology·2021
Same author

Skin masses in dogs under one year of age.

The Journal of small animal practice·2021
Same author

Effect of baseline disease severity on achievement of treatment target with apremilast: results from a pooled analysis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same journal

Exosomes in Dermatology.

Skin therapy letter·2026
Same journal

Zasocitinib: New Frontier in Tyrosine Kinase 2 Inhibition.

Skin therapy letter·2026
Same journal

Erratum to: Deuruxolitinib for Alopecia Areata.

Skin therapy letter·2026
Same journal

Advances in the Management of Hyperhidrosis.

Skin therapy letter·2026
Same journal

Topical Ruxolitinib for the Treatment of Hidradenitis Suppurativa.

Skin therapy letter·2026
Same journal

Icotrokinra: A Promising Oral IL-23 Receptor Inhibitor for Moderate-to-Severe Plaque Psoriasis.

Skin therapy letter·2026
See all related articles

Area of Science:

  • Dermatology
  • Pharmacology

Background:

  • Topical corticosteroids are a cornerstone of psoriasis therapy.
  • Patient reluctance towards systemic treatments is increasing.

Purpose of the Study:

  • To review alternative topical treatments for psoriasis.
  • To highlight the growing importance of topical psoriasis therapies.

Main Methods:

  • Literature review of existing psoriasis treatment options.
  • Analysis of topical agents beyond corticosteroids.

Main Results:

  • Several effective topical treatments exist, including tar, anthralin, tazarotene, calcipotriol, topical PUVA, and topical porphyrin derivatives.
  • These alternatives provide valuable options for psoriasis management.

Related Experiment Videos

Conclusions:

  • A diverse range of topical therapies can effectively manage psoriasis.
  • Topical treatments are poised to play a more significant role in psoriasis care due to patient preference for non-systemic options.